Clinical trial
Real-world Dosing Patterns of Rivaroxaban in the United States (RIVA-D)
NCT03242278 is registered in ClinicalTrials.gov with Bayer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Real-world Dosing Patterns of Rivaroxaban in the United States (RIVA-D)
- Lead sponsor
- Bayer
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 12, 2016
- Completion date
- March 1, 2016
- Enrollment
- 12,507 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.